NuVasive creates 2 executive leadership roles

NuVasive has created two new executive leadership roles, the company announced Sept. 1.

Advertisement

Massimo Calafiore was appointed chief commercial officer, and Ryan Donahoe was appointed chief technology officer. Both will report to CEO J. Christopher Barry.

Mr. Calafiore will oversee product marketing, commercial and commercial enablement functions. Mr. Donahoe will lead spine research and development.

“This new structure puts in place leaders who have decades of spine and orthopedics experience to advance our near- and long-term strategy as we continue to globalize and scale our business,” Mr. Barry said.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.